Eltoukhy Helmy's most recent trade in Guardant Health Inc was a trade of 23,997 Restricted Stock Units done . Disclosure was reported to the exchange on June 30, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 23,997 | 47,995 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 23,997 | 2,038,305 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 170.77 per share. | 30 Jun 2026 | 17,086 | 2,030,934 (2%) | 0% | 170.8 | 2,917,776 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 9,715 | 2,048,020 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 9,715 | 58,296 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 2,817 | 5,634 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 2,817 | 2,015,736 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 150.03 per share. | 30 Jun 2026 | 1,428 | 2,014,308 (2%) | 0% | 150.0 | 214,243 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 125.57 per share. | 05 Jun 2026 | 49,716 | 2,063,203 (2%) | 0% | 125.6 | 6,242,788 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 126.33 per share. | 05 Jun 2026 | 33,843 | 2,029,360 (2%) | 0% | 126.3 | 4,275,261 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 128.25 per share. | 05 Jun 2026 | 13,787 | 2,014,473 (2%) | 0% | 128.3 | 1,768,198 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 127.02 per share. | 05 Jun 2026 | 1,100 | 2,028,260 (2%) | 0% | 127.0 | 139,727 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 131.78 per share. | 05 Jun 2026 | 900 | 2,013,019 (2%) | 0% | 131.8 | 118,606 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 130.21 per share. | 05 Jun 2026 | 554 | 2,013,919 (2%) | 0% | 130.2 | 72,134 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 132.55 per share. | 05 Jun 2026 | 100 | 2,012,919 (2%) | 0% | 132.6 | 13,255 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2026 | 23,997 | 71,992 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2026 | 23,997 | 2,120,290 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.15 per share. | 31 Mar 2026 | 17,087 | 2,112,919 (2%) | 0% | 91.1 | 1,557,480 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2026 | 9,716 | 68,011 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2026 | 9,716 | 2,130,006 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2026 | 2,817 | 8,451 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2026 | 2,817 | 2,097,721 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.37 per share. | 31 Mar 2026 | 1,428 | 2,096,293 (2%) | 0% | 92.4 | 131,904 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 101,409 | 101,409 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 38,283 | 77,727 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 38,283 | 2,101,009 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 26,961 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 26,961 | 2,108,568 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.14 per share. | 01 Jan 2026 | 19,402 | 2,081,607 (2%) | 0% | 102.1 | 1,981,720 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.49 per share. | 01 Jan 2026 | 13,664 | 2,094,904 (2%) | 0% | 85.5 | 1,168,135 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 01 Jan 2026 | 13,209 | 0 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 01 Jan 2026 | 13,209 | 2,062,726 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 11,268 | 11,268 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 2,049,517 | 2,049,517 (2%) | 2% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 2,049,517 | 13,209 (0%) | 2% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 23,997 | 2,073,514 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 23,997 | 95,989 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.14 per share. | 31 Dec 2025 | 10,788 | 2,062,726 (2%) | 0% | 102.1 | 1,101,886 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 4,815 | 0 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 4,815 | 2,051,958 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.14 per share. | 31 Dec 2025 | 2,441 | 2,049,517 (2%) | 0% | 102.1 | 249,324 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 103.80 per share. | 15 Dec 2025 | 83,945 | 2,053,763 (2%) | 0% | 103.8 | 8,713,592 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 104.02 per share. | 15 Dec 2025 | 6,620 | 2,047,143 (2%) | 0% | 104.0 | 688,628 | Common Stock |
| Guardant Health Inc | Eltoukhy Helmy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2025 | 23,997 | 2,149,870 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Eltoukhy Helmy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2025 | 23,997 | 119,986 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Eltoukhy Helmy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.65 per share. | 30 Sep 2025 | 12,162 | 2,137,708 (2%) | 0% | 62.6 | 761,949 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2025 | 4,814 | 2,128,313 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2025 | 4,814 | 4,815 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.48 per share. | 30 Sep 2025 | 2,440 | 2,125,873 (2%) | 0% | 62.5 | 152,451 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 59.44 per share. | 09 Sep 2025 | 294,723 | 2,128,776 (2%) | 0% | 59.4 | 17,519,720 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 59.93 per share. | 09 Sep 2025 | 5,277 | 2,123,499 (2%) | 0% | 59.9 | 316,275 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 23,997 | 143,983 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 23,997 | 2,435,661 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.71 per share. | 30 Jun 2025 | 12,162 | 2,423,499 (2%) | 0% | 50.7 | 616,735 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 4,815 | 9,629 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 4,815 | 2,414,105 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.04 per share. | 30 Jun 2025 | 2,441 | 2,411,664 (2%) | 0% | 52.0 | 127,030 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 23,998 | 2,421,453 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 23,998 | 167,980 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.47 per share. | 31 Mar 2025 | 12,163 | 2,409,290 (2%) | 0% | 42.5 | 516,563 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 4,814 | 14,444 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 4,814 | 2,399,895 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.60 per share. | 31 Mar 2025 | 2,440 | 2,397,455 (2%) | 0% | 42.6 | 103,944 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 68,769 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 68,769 | 2,429,934 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.89 per share. | 14 Mar 2025 | 34,853 | 2,395,081 (2%) | 0% | 42.9 | 1,494,845 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 116,010 | 116,010 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 19,258 | 19,258 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 94,555 | 191,978 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 94,555 | 2,404,474 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.55 per share. | 31 Dec 2024 | 43,309 | 2,361,165 (2%) | 0% | 30.6 | 1,323,090 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 11,462 | 0 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 11,462 | 2,315,728 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.55 per share. | 31 Dec 2024 | 5,809 | 2,309,919 (2%) | 0% | 30.6 | 177,465 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 11,461 | 11,462 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 11,461 | 2,310,075 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.94 per share. | 30 Sep 2024 | 5,809 | 2,304,266 (2%) | 0% | 22.9 | 133,258 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 11,462 | 22,923 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 11,462 | 2,304,423 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.88 per share. | 30 Jun 2024 | 5,809 | 2,298,614 (2%) | 0% | 28.9 | 167,764 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.18 per share. | 03 May 2024 | 200,000 | 2,292,961 (2%) | 0% | 4.2 | 836,000 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 200,000 | 511,612 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 11,461 | 34,385 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 11,461 | 2,097,470 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.63 per share. | 31 Mar 2024 | 4,509 | 2,092,961 (2%) | 0% | 20.6 | 93,021 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 18 Mar 2024 | 1,130,382 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 286,533 | 286,533 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 45,846 | 45,846 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Eltoukhy Helmy | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 21 Jul 2023 | 365,775 | 0 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Eltoukhy Helmy | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 21 Jul 2023 | 164,716 | 164,716 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 21 Jul 2023 | 164,288 | 164,288 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 21 Jul 2023 | 36,771 | 2,086,009 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 26.33 per share. | 14 Mar 2023 | 84,452 | 2,040,638 (2%) | 0% | 26.3 | 2,223,908 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 26.15 per share. | 14 Mar 2023 | 8,600 | 2,049,238 (2%) | 0% | 26.2 | 224,928 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 97.90 per share. | 19 Nov 2021 | 37,591 | 1,889,277 (2%) | 0% | 97.9 | 3,680,317 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 93.04 per share. | 19 Nov 2021 | 26,394 | 1,931,186 (2%) | 0% | 93.0 | 2,455,811 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 96.83 per share. | 19 Nov 2021 | 14,900 | 1,956,086 (2%) | 0% | 96.8 | 1,442,774 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 98.75 per share. | 19 Nov 2021 | 12,409 | 1,901,686 (2%) | 0% | 98.8 | 1,225,446 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 95.50 per share. | 19 Nov 2021 | 5,000 | 1,941,186 (2%) | 0% | 95.5 | 477,500 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 94.00 per share. | 19 Nov 2021 | 5,000 | 1,936,186 (2%) | 0% | 94 | 470,000 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 92.23 per share. | 19 Nov 2021 | 3,106 | 1,904,792 (2%) | 0% | 92.2 | 286,481 | COMMON STOCK |